302 related articles for article (PubMed ID: 20953506)
1. Network based analysis of hepatitis C virus core and NS4B protein interactions.
Tripathi LP; Kataoka C; Taguwa S; Moriishi K; Mori Y; Matsuura Y; Mizuguchi K
Mol Biosyst; 2010 Dec; 6(12):2539-53. PubMed ID: 20953506
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study.
Tripathi LP; Kambara H; Moriishi K; Morita E; Abe T; Mori Y; Chen YA; Matsuura Y; Mizuguchi K
J Proteome Res; 2012 Jul; 11(7):3664-79. PubMed ID: 22646850
[TBL] [Abstract][Full Text] [Related]
3. Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy.
Li S; Yu X; Guo Y; Kong L
Cell Microbiol; 2012 Jul; 14(7):994-1002. PubMed ID: 22329740
[TBL] [Abstract][Full Text] [Related]
4. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
Large MK; Kittlesen DJ; Hahn YS
J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins.
Pazienza V; Clément S; Pugnale P; Conzelmann S; Pascarella S; Mangia A; Negro F
Liver Int; 2009 May; 29(5):661-9. PubMed ID: 18803589
[TBL] [Abstract][Full Text] [Related]
6. Prolactin Regulatory Element Binding Protein Is Involved in Hepatitis C Virus Replication by Interaction with NS4B.
Kong L; Fujimoto A; Nakamura M; Aoyagi H; Matsuda M; Watashi K; Suzuki R; Arita M; Yamagoe S; Dohmae N; Suzuki T; Sakamaki Y; Ichinose S; Suzuki T; Wakita T; Aizaki H
J Virol; 2016 Jan; 90(6):3093-111. PubMed ID: 26739056
[TBL] [Abstract][Full Text] [Related]
7. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
8. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles.
Dou J; Liu P; Wang J; Zhang X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1794-800. PubMed ID: 17074016
[TBL] [Abstract][Full Text] [Related]
9. Identification of in vivo interaction between Hepatitis C Virus core protein and 5' and 3' UTR RNA.
Yu KL; Jang SI; You JC
Virus Res; 2009 Nov; 145(2):285-92. PubMed ID: 19665505
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3.
Owsianka AM; Patel AH
Virology; 1999 May; 257(2):330-40. PubMed ID: 10329544
[TBL] [Abstract][Full Text] [Related]
11. [Gene expression profiles on three kinds of genotype hepatitis C virus core protein in Huh-7 cell line with microarray analysis].
Dou J; Wang J; Liu PB; Zhang XJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):38-41. PubMed ID: 16620599
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
Chang S; Dolganiuc A; Szabo G
J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
[TBL] [Abstract][Full Text] [Related]
13. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
Sakamoto H; Okamoto K; Aoki M; Kato H; Katsume A; Ohta A; Tsukuda T; Shimma N; Aoki Y; Arisawa M; Kohara M; Sudoh M
Nat Chem Biol; 2005 Nov; 1(6):333-7. PubMed ID: 16408072
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
Cheng PL; Chang MH; Chao CH; Lee YH
Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.
Khan M; Jahan S; Khaliq S; Ijaz B; Ahmad W; Samreen B; Hassan S
Arch Virol; 2010 Nov; 155(11):1735-53. PubMed ID: 20842391
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory.
Gouttenoire J; Penin F; Moradpour D
Rev Med Virol; 2010 Mar; 20(2):117-29. PubMed ID: 20069613
[TBL] [Abstract][Full Text] [Related]
17. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
18. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
[TBL] [Abstract][Full Text] [Related]
19. Reticulon 3 interacts with NS4B of the hepatitis C virus and negatively regulates viral replication by disrupting NS4B self-interaction.
Wu MJ; Ke PY; Hsu JT; Yeh CT; Horng JT
Cell Microbiol; 2014 Nov; 16(11):1603-18. PubMed ID: 24898729
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of lipid droplets induced by the hepatitis C virus core protein.
Lyn RK; Kennedy DC; Stolow A; Ridsdale A; Pezacki JP
Biochem Biophys Res Commun; 2010 Sep; 399(4):518-24. PubMed ID: 20678475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
